Site records / Maharashtra / FEI 3003973520
Centaur Pharmaceuticals Private LimitedThane, Maharashtra
FDA-registered drug establishment in Thane, Maharashtra: analysis, api manufacture. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.
- Inspections posted
- 6
- Last inspection
- Jul 2025 · VAI
- Warning letters to this FEI
- 1
- Import alerts at this address
- 0
- US border refusals, 2 years
- 0
This site, graded.
Every fact sourced.
- A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
- Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
- Warning-letter violations, numbered and labelled
- Import-alert history rebuilt from the archive, each listing checked against this address
- Border refusals by product, and the company's other sites, each graded
- A hash of every source read, so the PDF can be checked against the record
On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.
PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.
By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.
Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan
Inspections
6 FDA inspections of this FEI, by end date; 6 with a posted classification.
- 25 Jul 2025VAI · Voluntary Action IndicatedDrug Quality Assurance · no citations posted
- 21 Nov 2022OAI · Official Action IndicatedDrug Quality Assurance · no citations posted
- 27 Sep 2019VAI · Voluntary Action IndicatedDrug Quality Assurance · no citations posted
- 13 Oct 2016NAI · No Action IndicatedDrug Quality Assurance · no citations posted
- 5 Feb 2015NAI · No Action IndicatedDrug Quality Assurance · no citations posted
- 11 Aug 2011VAI · Voluntary Action IndicatedDrug Quality Assurance · no citations posted
Warning letters and compliance actions
- 5 Jun 2023Warning Letter · CDER SourceCGMP/Active Pharmaceutical Ingredient (API)/Adulterated
- 25 Jul 2023Warning letter to Centaur Pharmaceuticals Private Ltd. SourceCGMP/Finished Pharmaceuticals/Adulterated · issued to the firm name; FDA does not tie it to this FEI
- 8 Jan 2010Warning letter to Centaur, Inc. SourceCGMP/Finished Pharmaceuticals/Adulterated · issued to the firm name; FDA does not tie it to this FEI
Import alerts in force
No listing in force under this firm's name.
Other registered sites of Centaur Pharmaceuticals Private Limited
- Centaur Pharmaceuticals Private LimitedPune, Maharashtra
- Centaur Pharmaceuticals Private LimitedPernem, Goa
Registration
- FEI
- 3003973520
- DUNS
- 915838629
- Registered as
- Centaur Pharmaceuticals Private Limited
- Registrant
- Centaur Pharmaceuticals Private Limited
- Address
- Plot No. 75,76,76/1 & 74 Chikhloli, MIDC, Ambernath (West),Thane, Maharashtra 421501, India (IND)
- Operations
- ANALYSIS, API MANUFACTURE
- Registration expires
- 31 Dec 2026
Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.